Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
BACKGROUND AND OBJECTIVE: The demonstration of HER2 in gastric adenocarcinoma (GA) tissues by immunohistochemistry assists in deciding whether targeted therapy would optimise the treatment of GA patients who are HER2 positive. However, this has not been extensively studied in our patients hence the...
| Format: | Article |
|---|---|
| Published: |
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|